Using GSK and Dynavax tech, Clover kick-starts COVID-19 vax trial with data drop in August

Using GSK and Dynavax tech, Clover kick-starts COVID-19 vax trial with data drop in August

Source: 
Fierce Biotech
snippet: 

After teaming up with GlaxoSmithKline and Dynavax early on in the pandemic, Chinese biotech Clover Biopharmaceuticals has started trials of its COVID-19 vaccine and expects data in August.